Section to complete information about the primary medical condition(s) or problem(s) studied and, a characteristics of the intervention(s).
Health condition(s) or Problem(s) studied:
Health condition(s) code:
Tetanus
Diphtheria
Clostridium Infections
Gram-Positive Bacterial Infections
Bacterial Infections
Corynebacterium Infections
Actinomycetales Infections
Intervention(s):
The adolescents were randomly distributed in two groups, respectively immunized with the adult d.T. candidate vaccine, or the control vaccine IMOVAX d.T. adult, bivalent vaccines against tetanus and diphtheria. A single dose of 0,5 mL by intramuscular route was used. The study vaccine was developed by Finlay Institute and is composed of purified diphtheria toxoid (1,5 Lf) and purified tetanus toxoid (5 Lf). Aluminum hydroxide is used as adjuvant.
Intervention code:
Diphtheria-Tetanus Vaccine
Vaccines
Injections, Intramuscular